Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 07:11 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 9,196,186 9.99% | 3,454,247 (+60.16%) | View |
| 2024-02-13 5:54 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | JANUS HENDERSON GROUP PLC JHG | 11,125,330 12.4% | 1,681,688 (+17.81%) | View |
| 2024-02-13 4:39 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 5,685,350 6.33% | 494,745 (+9.53%) | View |
| 2024-02-13 09:40 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 6,751,782 7.51% | 3,957,109 (+141.59%) | View |
| 2024-02-12 08:20 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,716,242 4.1% | 594,142 (+19.03%) | View |
| 2023-08-10 3:25 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | JANUS HENDERSON GROUP PLC JHG | 9,443,642 12.3% | 9,443,642 (New Position) | View |
| 2023-03-09 4:13 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,122,100 5.1% | 265,110 (+9.28%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 5,190,605 8.4% | 1,015,623 (+24.33%) | View |
| 2023-02-14 10:01 am Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 5,741,939 9.3% | -68,201 (-1.17%) | View |
| 2023-02-13 5:42 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Vivo Opportunity LLC | 2,251,663 3.6% | -149,613 (-6.23%) | View |
| 2023-02-13 4:58 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 2,856,990 4.6% | -583,222 (-16.95%) | View |
| 2022-06-06 4:57 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,440,212 5.8% | 3,440,212 (New Position) | View |
| 2022-06-03 4:10 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 4,174,982 7.07% | 4,174,982 (New Position) | View |
| 2022-02-14 10:40 am Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 2,794,673 4.8% | -233,032 (-7.70%) | View |
| 2022-02-14 08:12 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 5,810,140 9.99% | 422,627 (+7.84%) | View |
| 2022-02-11 5:21 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Vivo Opportunity LLC | 2,401,276 4.1% | -481,548 (-16.70%) | View |
| 2022-02-11 10:07 am Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Avoro Capital Advisors LLC | 1,670,000 2.9% | -2,695,000 (-61.74%) | View |
| 2022-02-08 12:44 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | BRANDES INVESTMENT PARTNERS LP | 2,599,633 4.43% | -362,245 (-12.23%) | View |
| 2022-01-21 11:12 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | COWEN AND COMPANY LLC | 3,732,778 6.37% | 691,154 (+22.72%) | View |
| 2021-11-12 2:11 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | COWEN AND COMPANY LLC | 3,041,624 5.18% | 3,041,624 (New Position) | View |